Novartis AG | Balance Sheet
Fiscal year is January-December. All values CHF Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,202
13,774
5,452
7,904
9,243
15,725
Total Accounts Receivable
11,226
10,190
10,562
10,369
9,813
9,539
Inventories
6,463
6,054
6,232
6,357
6,692
6,857
Other Current Assets
1,272
7,304
622
708
1,740
2,937
Total Current Assets
27,163
37,322
22,868
25,339
27,489
35,058
Net Property, Plant & Equipment
16,184
15,882
15,998
15,897
16,044
15,473
Total Investments and Advances
9,287
9,756
16,594
15,652
16,221
9,650
Long-Term Note Receivable
271
332
1,084
980
576
552
Intangible Assets
52,353
52,806
65,456
63,339
60,172
72,962
Other Assets
467
550
722
848
1,165
1,225
Total Assets
112,609
124,967
132,037
132,519
129,833
143,578
ST Debt & Current Portion LT Debt
5,935
6,518
5,610
6,002
5,173
Accounts Payable
5,468
5,385
5,674
4,953
5,037
Income Tax Payable
2,187
2,063
2,270
2,185
1,679
Other Current Liabilities
9,861
12,836
10,178
9,433
10,917
Total Current Liabilities
23,450
26,802
23,732
22,572
22,806
Long-Term Debt
9,998
13,711
16,343
18,190
22,632
Provision for Risks & Charges
5,557
6,717
7,380
7,127
5,526
Deferred Taxes
419
1,883
2,605
3,432
2,983
Other Liabilities
907
906
672
1,482
1,351
Total Liabilities
46,378
54,573
54,838
56,403
57,498
Common Equity (Total)
66,117
70,317
77,123
76,056
72,277
Total Shareholders' Equity
66,117
70,317
77,123
76,056
72,277
Total Equity
66,232
70,394
77,199
76,115
72,334
Liabilities & Shareholders' Equity
112,609
124,967
132,037
132,519
129,833
Accumulated Minority Interest
115
78
76
60
57
About Novartis
View Profile
